BioCatalystWatch
OKURWorkspace / OKUR / OverviewCompany library
ONKURE THERAPEUTICS, INC. logo

ONKURE THERAPEUTICS, INC.

ONKURE THERAPEUTICS, INC. (OKUR)

Website

Featured programme · OKI-345

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

OKI-345

Mutant PI3Kα (pan-mutant)

Upcoming / outlook

OKI-355

Mutant PI3Kα (pan-mutant)

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

OKI-355

Mutant PI3Kα (pan-mutant)

Upcoming / outlook

OKI-345

Mutant PI3Kα (pan-mutant)

Upcoming / outlook

Other pipelines

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Market Reaction / Supply Context

Market Structure

OKUR PR & News

PR & News

OKUR SEC archive